Back to Top
Trastuzumab Biosimilar - APC Research Grade
Add recommended extras
Trastuzumab Biosimilar - APC Research Grade
| Concentration | 0.2mg/ml |
|---|---|
| Isotype | Human IgG1 Kappa |
| Host | Humanized |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Application Notes | Excitation laser Red Laser (650 nm). Each investigator should determine their own optimal working dilution for specific applications. |
| Applications | Flow Cytometry, IHC |
| Storage | This Allophycocyanin (APC) conjugate is stable when stored at 2-8°C. Do not freeze. |
| Formulation | This Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. |
| Specificity | Detects human ErbB2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Trastuzumab. |
| Species Reactivity | Human |
| Target | HER2 |
| Shipping Conditions | Blue ice |
| background | Trastuzumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab is produced by recombinant DNA technology in a mamma |
| Other names | Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |
Write Your Own Review
Who Viewed This Also Viewed
Girentuximab Vedotin Biosimilar - Research Grade
$700.00 - $3,024.00
Talacotuzumab Vedotin Biosimilar - Research Grade
$700.00 - $3,024.00
